GC Wealth Management RIA’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.2M Sell
6,073
-263
-4% -$90K 0.13% 143
2026
Q1
$2.23M Sell
6,336
-415
-6% -$148K 0.09% 150
2025
Q4
$2.21M Sell
6,751
-5,876
-47% -$1.86M 0.08% 154
2025
Q3
$3.56M Buy
12,627
+4,340
+52% +$1.26M 0.12% 138
2025
Q2
$2.31M Buy
8,287
+3,614
+77% +$1.02M 0.19% 119
2025
Q1
$1.46M Buy
4,673
+209
+5% +$61.7K 0.27% 85
2024
Q4
$1.16M Buy
4,464
+220
+5% +$65.3K 0.2% 101
2024
Q3
$1.37M Sell
4,244
-172
-4% -$56.3K 0.24% 86
2024
Q2
$1.38M Buy
4,416
+8
+0.2% +$2.35K 0.27% 76
2024
Q1
$1.25M Buy
4,408
+3,463
+366% +$1.01M 0.25% 81
2023
Q4
$272K Buy
+945
New +$257K 0.12% 170

Other funds holding AMGN

GC Wealth Management RIA's AMGN Position: Q2 2026 in Review

GC Wealth Management RIA reduced its Amgen (AMGN) stake by 4.2% in Q2 2026, selling an estimated $90K and leaving 6,073 shares worth $2.2M. The position accounts for 0.13% of the portfolio, ranked #143.

GC Wealth Management RIA first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. The position peaked at $3.56M in Q3 2025. 1,372 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • GC Wealth Management RIA held 6,073 shares of Amgen worth $2.2M as of Q2 2026.
  • GC Wealth Management RIA sold 263 Amgen shares in Q2 2026, an estimated $90K.
  • Amgen made up 0.13% of GC Wealth Management RIA's portfolio in Q2 2026, its #143 holding.
  • GC Wealth Management RIA first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
  • GC Wealth Management RIA's Amgen position peaked at $3.56M in Q3 2025.
  • 1,372 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on GC Wealth Management RIA's 13F filing for Q2 2026, filed 16 Jul 2026.